Carman Alenson
Comptroller/Controller/Auditor en PRIME MEDICINE, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Carman Alenson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01/08/2021 | - |
| Director Financiero/CFO | 01/08/2021 | 17/01/2024 |
Historial de carrera de Carman Alenson
Antiguos cargos conocidos de Carman Alenson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07/11/2016 | 30/07/2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2015 | 01/10/2016 |
Formación de Carman Alenson.
| Boston University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Carman Alenson
- Experiencia
